Kidney Cancer Coverage from Every Angle

Daniel P. Petrylak, MD, on Supporting Patients Considering a Clinical Trial

Posted: Monday, July 8, 2019

Daniel P. Petrylak, MD, of Yale School of Medicine, discusses ways that his team provides support for patients with urothelial cancer who have been treated with platinum therapy and immune checkpoint inhibitors and are facing the prospect of a clinical trial for newer treatments.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.